Abbott launches over-the-counter continuous glucose monitor in the US

Abbott (ABT.N), opens new tab has launched its over-the-counter continuous glucose monitoring system Lingo in the U.S., days after a rival started marketing its product.

Lingo is available for consumers 18 years and older not on insulin in three payment options - $49 for two weeks, $89 for four weeks and $249 for 12 weeks, the company said on Thursday.